Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Copaíba da Amazônia is a Brazilian company specializing in the sustainable extraction and commercialization of medicinal oils and natural products derived from the Amazon rainforest. The company's flagship product is Copaiba oil, a resinous substance harvested from Copaifera trees, which is highly valued for its anti-inflammatory, antiseptic, and healing properties. Their product range includes pure oils, dietary supplements in capsule form, and topical formulations aimed at treating various dermatological and systemic conditions. By integrating traditional Amazonian knowledge with modern quality standards, the company provides natural healthcare solutions to both domestic and international markets. The company emphasizes ethical sourcing and the preservation of biodiversity while promoting the therapeutic benefits of Amazonian flora, particularly the bioactive sesquiterpene beta-caryophyllene.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Copaiba da Amazonia.